Carmine N. Stengone

Director & CEO and President

Director & CEO and President at Contineum Therapeutics, Inc., filing insider transactions between 2026-06-30 and 2026-09-08.

Total Purchases

—

0 transactions

Total Sales

$241K

3 transactions

Companies Traded

3 total filings

Active Since

2026-06-30

Last: 2026-09-08

Companies

Contineum Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-08	CTNM	Sale	2,500	$16.46	$41K	17.2K	SEC ↗
2026-07-08	CTNM	Sale	2,500	$16.00	$40K	17.2K	SEC ↗
2026-06-30	CTNM	Sale	10.0K	$16.01	$160K	17.2K